Literature DB >> 1996330

Mechanism of glucoregulatory responses to stress and their deficiency in diabetes.

P D Miles1, K Yamatani, H L Lickley, M Vranic.   

Abstract

During exercise, increased energy demands are met by increased glucose production that occurs simultaneously with the increased glucose uptake. We had previously observed that, during exercise, metabolic clearance rate of glucose (MCR) increases markedly in normal, but only marginally in poorly controlled diabetic dogs. We wished to determine (i) whether in a more general model of stress matched increases in rate of appearance of glucose and MCR also occur, or if MCR is suppressed, as during catecholamine infusion; and (ii) whether diabetes affects stress-induced changes in rate of glucose appearance and MCR. Therefore, we injected carbachol (27 nmol/50 microliters), an analog of acetylcholine, intracerebroventricularly in seven conscious dogs before and after induction of alloxan diabetes. In normal dogs, plasma epinephrine and cortisol increased 4- to 5-fold, whereas norepinephrine and glucagon doubled. Plasma insulin, however, remained unchanged. Tracer-determined hepatic glucose production increased rapidly, but transiently, by 2.5-fold. This increment can be fully explained by the observed increments in the counterregulatory hormones. Surprisingly, however, MCR also promptly increased, and therefore, plasma glucose changed only marginally. After induction of diabetes, the animals were given intracerebroventricular carbachol while plasma glucose was maintained at moderate hyperglycemia (9.0 +/- 0.4 mM). Increments in counterregulatory hormones were similar to those seen in normal dogs, except for exaggerated norepinephrine release. Peripheral insulin levels were higher in diabetic than in normal dogs; however, MCR was markedly reduced and the lipolytic response to stress increased, indicating insulin resistance. Interestingly, the hyperglycemic response to stress was 6-fold greater in diabetic than normal animals, relating mainly to the failure of MCR to rise. Plasma lactate increased equivalently in diabetic and normal animals despite suppression of MCR in the diabetics, indicating either greater muscle glycogenolysis and/or impairment in glucose oxidation. We conclude that in this stress model MCR increases as in exercise in normal but not in diabetic dogs. We speculate that glucose uptake in stress could be mediated through an insulin-dependent neural mechanism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996330      PMCID: PMC51004          DOI: 10.1073/pnas.88.4.1296

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Influences of glucose loading and of injected insulin on hepatic glucose output.

Authors:  R STEELE
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

2.  Mechanism of plasma catecholamine increases during surgical stress in man.

Authors:  J B Halter; A E Pflug; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

3.  Exercise, insulin and glucose turnover in dogs.

Authors:  M Vranic; G A Wrenshall
Journal:  Endocrinology       Date:  1969-07       Impact factor: 4.736

4.  Glucose metabolism in severely burned patients.

Authors:  R R Wolfe; M J Durkot; J R Allsop; J F Burke
Journal:  Metabolism       Date:  1979-10       Impact factor: 8.694

5.  The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.

Authors:  M Vranic; R Kawamori; S Pek; N Kovacevic; G A Wrenshall
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

6.  Glucose metabolism in perfused skeletal muscle. Pyruvate dehydrogenase activity in starvation, diabetes and exercise.

Authors:  S A Hagg; S I Taylor; N B Ruberman
Journal:  Biochem J       Date:  1976-08-15       Impact factor: 3.857

7.  Differential effects of epinephrine on glucose production and disposal in man.

Authors:  R Rizza; M Haymond; P Cryer; J Gerich
Journal:  Am J Physiol       Date:  1979-10

8.  Experimental validation of measurements of glucose turnover in nonsteady state.

Authors:  J Radziuk; K H Norwich; M Vranic
Journal:  Am J Physiol       Date:  1978-01

9.  Somatostatin: central nervous system actions on glucoregulation.

Authors:  M Brown; J Rivier; W Vale
Journal:  Endocrinology       Date:  1979-06       Impact factor: 4.736

10.  Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.

Authors:  R A Rizza; P E Cryer; M W Haymond; J E Gerich
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

View more
  3 in total

1.  Site and mechanism of leptin action in a rodent form of congenital lipodystrophy.

Authors:  Esra Asilmaz; Paul Cohen; Makoto Miyazaki; Pawel Dobrzyn; Kohjiro Ueki; Gulnorakhon Fayzikhodjaeva; Alexander A Soukas; C Ronald Kahn; James M Ntambi; Nicholas D Socci; Jeffrey M Friedman
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs.

Authors:  A Giacca; S J Fisher; Z Q Shi; R Gupta; H L Lickley; M Vranic
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

3.  Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats.

Authors:  Jessica T Y Yue; Elena Burdett; David H Coy; Adria Giacca; Suad Efendic; Mladen Vranic
Journal:  Diabetes       Date:  2011-11-21       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.